Enhancing neuro-oncology care through equity-driven applications of artificial intelligence.

Journal: Neuro-oncology
Published Date: Nov 4, 2024

Abstract

The disease course and clinical outcome for brain tumor patients depend not only on the molecular and histological features of the tumor but also on the patient's demographics and social determinants of health. While current investigations in neuro-oncology have broadly utilized artificial intelligence (AI) to enrich tumor diagnosis and more accurately predict treatment response, postoperative complications, and survival, equity-driven applications of AI have been limited. However, AI applications to advance health equity in the broader medical field have the potential to serve as practical blueprints to address known disparities in neuro-oncologic care. In this consensus review, we will describe current applications of AI in neuro-oncology, postulate viable AI solutions for the most pressing inequities in neuro-oncology based on broader literature, propose a framework for the effective integration of equity into AI-based neuro-oncology research, and close with the limitations of AI.

Authors

  • Mulki Mehari
    Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA.
  • Youssef Sibih
    Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA.
  • Abraham Dada
    Department of Neurosurgery, University of California, San Francisco, San Francisco, California, USA.
  • Susan M Chang
    Department of Neurological Surgery, University of California, San Francisco, San Francisco, California, USA.
  • Patrick Y Wen
    Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
  • Annette M Molinaro
    Department of Neurological Surgery, University of California San Francisco, San Francisco, CA, USA.
  • Ugonma N Chukwueke
    Center for Neuro-Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
  • Joshua A Budhu
    Department of Neurology, Memorial Sloan Kettering Cancer Center, Department of Neurology, Weill Cornell Medicine, Joan & Sanford I. Weill Medical College of Cornell University, New York, New York, USA.
  • Sadhana Jackson
    Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
  • J Ricardo McFaline-Figueroa
    Center for Neuro-Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
  • Alyx Porter
    Division of Neuro-Oncology, Department of Neurology, Mayo Clinic, Phoenix, Arizona, USA.
  • Shawn L Hervey-Jumper
    Department of Neurosurgery, University of Michigan, Ann Arbor, MI, USA.

Keywords

External Resources

Popular Topics
Recent Journals